EcoDrugPlus

Solute Carrier Family 10 Member 2

Ensembl ID : ENSEEUG00000006543
Gene Symbol: SLC10A2
1 External references
211 Possible Orthologues:

Solute Carrier Family 18 Member A2

Ensembl ID : ENSEEUG00000009680
Gene Symbol: SLC18A2
1 External references
222 Possible Orthologues:

Solute Carrier Family 22 Member 6

Ensembl ID : ENSEEUG00000006456
Gene Symbol: SLC22A6
1 External references
495 Possible Orthologues:

Solute Carrier Family 22 Member 8

Ensembl ID : ENSEEUG00000008309
Gene Symbol: SLC22A8
1 External references
304 Possible Orthologues:

Solute Carrier Family 29 Member 1 (Augustine Blood Group)

Ensembl ID : ENSEEUG00000002865
Gene Symbol: SLC29A1
1 External references
280 Possible Orthologues:

Solute Carrier Family 5 Member 2

Ensembl ID : ENSEEUG00000010635
Gene Symbol: SLC5A2
1 External references
199 Possible Orthologues:

Solute Carrier Family 6 Member 1

Ensembl ID : ENSEEUG00000008585
Gene Symbol: SLC6A1
1 External references
279 Possible Orthologues:

Solute Carrier Family 6 Member 2

Ensembl ID : ENSEEUG00000014442
Gene Symbol: SLC6A2
1 External references
204 Possible Orthologues:

Solute Carrier Family 6 Member 4

Ensembl ID : ENSEEUG00000008087
Gene Symbol: SLC6A4
1 External references
205 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSEEUG00000002019
Gene Symbol: SLC6A9
1 External references
206 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSEEUG00000002520
Gene Symbol: SSTR1
1 External references
160 Possible Orthologues:

Somatostatin Receptor 3

Ensembl ID : ENSEEUG00000014716
Gene Symbol: SSTR3
1 External references
251 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).